Filing Details
- Accession Number:
- 0001209191-12-009681
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-13 21:31:41
- Reporting Period:
- 2012-02-10
- Filing Date:
- 2012-02-13
- Accepted Time:
- 2012-02-13 21:31:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1491874 | M. Geoffrey Parker | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-02-10 | 4,600 | $10.97 | 4,600 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $10.84 to $11.00 per share, inclusive. The Reporting Person will provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.